Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)
Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –
Incyte pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Incyte's pe ratio was 15.6× on Nov 11, 2026, against 17.6× a year earlier. Over the last 5 years it ranged from 13.7× to 532.8×, with a median of 21.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.6× | −1.1 |
| 2025 | Dec 31, 2025 | 16.7× | −476.7 |
| 2024 | Dec 31, 2024 | 493.4× | +460.1 |
| 2023 | Dec 29, 2023 | 33.2× | +12.8 |
| 2022 | Dec 30, 2022 | 20.4× | −10.0 |
| 2021 | Dec 31, 2021 | 30.5× | −17.2 |
| 2020 | Apr 30, 2020 | 47.6× | +0.7 |
| 2019 | Dec 31, 2019 | 46.9× | −183.2 |
| 2017 | Apr 28, 2017 | 230.2× | +101.6 |
| 2016 | Dec 30, 2016 | 128.6× | – |
See a number that looks wrong?